Phase 2 Vein Thrombosis Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg
ThrombosisSuperficial Vein ThrombosisSVT
Ottawa Hospital Research Institute50 enrolled2 locationsNCT06965998
Recruiting
Phase 2
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
Hepatocellular CarcinomaPortal Vein Thrombosis
Samsung Medical Center63 enrolled1 locationNCT05625893
Recruiting
Phase 2
Anticoagulant therapy for cancer-associated blood clots
Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis
South East Sydney and Illawarra Area Health Service600 enrolled5 locationsACTRN12617000331336
Completed
Phase 2
Once-daily oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis. The Einstein-DVT dose-finding study.
Acute symptomatic deep-vein thrombosis
Bayer Australia Ltd520 enrolled1 locationACTRN12605000597695